
### [NCIT:C4614](http://purl.obolibrary.org/obo/NCIT_C4614)
**Label:** Skin Papilloma

**Subclasses:** [NCIT:C4462](http://purl.obolibrary.org/obo/NCIT_C4462) (Squamous Cell Skin Papilloma), 

**Class expressions from DL-Learner:**

- Thing 53.20%
- [NCIT:C47826](http://purl.obolibrary.org/obo/NCIT_C47826) (Diffuse Lesion) 53.12%
- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 53.12%
- [NCIT:C36117](http://purl.obolibrary.org/obo/NCIT_C36117) (Invasive Lesion) 53.12%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 53.12%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39124](http://purl.obolibrary.org/obo/NCIT_C39124) (IL3 Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39123](http://purl.obolibrary.org/obo/NCIT_C39123) (IL2RB Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39121](http://purl.obolibrary.org/obo/NCIT_C39121) (IL22 Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39117](http://purl.obolibrary.org/obo/NCIT_C39117) (IL12 Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39114](http://purl.obolibrary.org/obo/NCIT_C39114) (IGF-1 Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39112](http://purl.obolibrary.org/obo/NCIT_C39112) (IFN Gamma Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39103](http://purl.obolibrary.org/obo/NCIT_C39103) (ERBB2 Signaling Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39102](http://purl.obolibrary.org/obo/NCIT_C39102) (Skeletal Myogenesis Pathway))) 38.48%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39101](http://purl.obolibrary.org/obo/NCIT_C39101) (Human Cytomegalovirus Infection Pathway))) 38.48%


